Herman (Herm) Sullivan, MD, has accepted the position of medical director of Mercy Health Hauenstein Neurosciences, effective in October 2018.
Since Philip Gorelick, MD, resigned as medical director in January 2018, Sullivan has admirably fulfilled these duties on an interim basis. Now, after a nationwide search led by a committee of West Michigan Mercy Health physician and administrative leadership, Sullivan has been selected as the permanent leader of the program. In this role, he will continue to advance the Mercy Health Hauenstein Neurosciences program as the most complete and advanced neurosciences program in West Michigan.
A graduate of Harvard University, Sullivan then received his medical degree from the University of North Carolina. He completed his internship and neurology residency at Case Western Reserve University followed by a fellowship at Stanford University. Sullivan is a respected neurologist with special expertise in the diagnosis and treatment of multiple sclerosis. He has experience conducting neurologic research for a variety of conditions in industry as well as in the clinical setting.
Sullivan has served as medical director of the Mercy Health Multiple Sclerosis Program. In 2015, he earned the Molina Healthcare Community Award for his work with multiple sclerosis. In addition to caring directly for his patients, Sullivan is also a champion of the Saint Mary’s Foundation and is a ‘Grand Guy.’
“Herm is exceptionally accomplished, and it was evident to the search committee that he stood out among the other candidates, in aligning with the mission, vision and values of Mercy Health” according to David Baumgartner, MD, chief medical officer for Mercy Health Saint Mary’s.
We wish Dr. Sullivan well in this role.